DOI:
10.1055/s-00000058
Planta Medica
LinksClose Window
References
Fujimori Y, Katsuno K, Nakashima I, Ishikawa-Takemura Y, Fujikura H, Isaji M.
Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models.
J Pharmacol Exp Ther 2008;
327: 268-276
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.